The Conscious Fund ‘at the forefront of psychedelic medicine investing’

‘s Richard Skaife speaks to Proactive London’s Katie Pilbeam about their latest investments into global early-stage ventures in psychedelic medicine.

Skaife outlines the new ‘category’ that has been created over the last twelve months in regards to psychedelic medicine, which he believes as a fund they have been at the forefront of.

Despite all of the challenges, 2020 was a success, especially with the virtual Psychedelic Capital investor event on June 30th.

With four transactions to announce already this quarter and plans to fulfill up to 30 investments in 2021, it’s set to be a busy year for .